In August 2011, the European Society of Cardiology and the European Atherosclerosis Society released new guidelines for the management of patients with dyslipidemias, which consider low LDL cholesterol levels still as the primary treatment ... J Golob,S Brus,M Gro�Elj,... - Aihce-health Care...
Japan ASi. Japan Atherosclerosis Society (JAS) guidelines for diagnosis and treatment of 1 atherosclerotic cardiovascular disease. Tokyo: JAS; 2002. 2 [34] Shima K, Kuwajima M. Standardization for glycohemoglobin (HbA1c) measurements 3 and its evaluation. Nippon Rinsho. 1998;56 Suppl 3:59-67....
Reduced macrophage iron level, either through treatment with an iron chelator [86] or an iron-deficient diet [87], reduced atherosclerosis, implying that decreased intracellular iron level protects against atherosclerosis. Moreover, in a posthoc analysis of the Iron in Atherosclerosis Study (FeAST)...
Objective Puerarin (PU) is a natural compound that exhibits limited oral bioavailability but has shown promise in the treatment of atherosclerosis (AS). However, the precise mechanisms underlying its therapeutic effects remain incompletely understood. This study aimed to investigate the effects of PU an...
In the study, they observed a decrease in the amount of inflammation and a decrease in the amount of drug in the plaque, which indicates the positive effect of this type of treatment on controlling the stability of the plaque. The synthesis of small-scale metal–organic frameworks (MOFs) ...
Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies Hannah Kaiser Charlotte Näslund-Koch Lone Skov Dermatology and Therapy (2024) Translational Molecular Imaging Tool of Vulnerable Carotid Plaque: Evaluate Effects of Statin Thera...
Early atherosclerosis could be identified through this method, and it maybe be helpful for clinical treatment. Scientific REPOrTS | 7:7032 | DOI:10.1038/s41598-017-06127-w 7 www.nature.com/scientificreports/ References 1. Balami, J. S. et al. A systematic review and meta-analysis of ...
REVIEW ARTICLEAtherosclerosis: Current Status of Preventionand TreatmentThomas F. Whayne, Jr., M.D., Ph.D., F.I.C.A. 1ABSTRACTThe reality of regression of atherosclerotic plaques was established as long ago as1987 by aggressive cholesterol reduction even before the era of statin therapy. ...
28 The favorable effects of alirocumab on coronary atherosclerosis were observed at mean LDL-C levels while receiving treatment below the treatment goals recommended in current guidelines.29 These findings might provide the mechanistic rationale in favor of early initiation of very intensive LDL-C–...
who have had PROBUCOL since conception, were weaned at three weeks of age. They continued to receive PROBUCOL in the chow. At 6 weeks, when typically 50% of the animals are dead in the absence of treatment, there is no abnormal phenotype, as measured by MRI of...